Medical devices

Jenn Wong, Abbott's divisional VP of global clinical and regulatory affairs, and Dr. Joshua Eloge, Rush associate director of the Woman's Board Depression Treatment Research Center, discuss their research on treatment-resistant depression.

Also, a project developing an AI-powered application for preventing cognitive decline among seniors has won a $2 million grant from the New Zealand government.

Also, OMRON in Singapore has launched a new medical device plan featuring AI-driven recommendations for self-management of chronic diseases.

Also, a Taiwanese startup has received the US FDA's 510(k) clearance for its neurosurgical robot.

Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as natural extensions of the human body.

Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.

Anne Osdoit, CEO of Moon Surgical, says the company’s robotic surgery offering serves as a surgical assistant in laparoscopic soft tissue procedures, using robotic arms to hold instruments and AI to give insights into workflow efficiency.

Nissan Elimelech, founder of Augmedics, shares how the company's augmented reality surgical technology projects an anatomically accurate 3D spine onto the patient, helping surgeons operate with their eyes on the body instead of a screen.  

Also, VUNO has obtained regulatory clearance in South Korea for its AI-based screening solution for kidney failure.